Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer (OvCa)”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07117877
What this trial is testing

Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer

Who this might be right for
Platinum Resistant Ovarian CancerPlatinum Refractory Epithelial Ovarian CancerOvarian Cancer (OvCa)
Fudan University 33
Not applicableLooking for participantsNCT07616310
What this trial is testing

Rectosigmoid Lesion Excision vs. Resection: A Non-Inferiority Randomized Comparison in Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer (OvCa)
Second Affiliated Hospital, Zhejiang University, School of Medicine 300
Not applicableLooking for participantsNCT07100288
What this trial is testing

Anatomopathological Analysis of the Infundibulopelvic Ligament in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerOvarian Cancer (OvCa)Ovarian Adenocarcinoma
Complejo Hospitalario Universitario Insular Materno Infantil 200
Not applicableStudy completedNCT07154966
What this trial is testing

Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy

Who this might be right for
Ovarian Cancer (OvCa)Fallopian Tube CancersEndometrial Cancer+3 more
Ankara Etlik City Hospital 102
Testing effectiveness (Phase 2)Looking for participantsNCT07340164
What this trial is testing

Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy

Who this might be right for
Ovarian CancerOvarian Carcinoma, RecurrentOvarian Cancer Metastatic Recurrent+1 more
Yonsei University 116
Not applicableLooking for participantsNCT06760923
What this trial is testing

Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

Who this might be right for
Ovarian Cancer (OvCa)
Xiangya Hospital of Central South University 240
Not applicableStudy completedNCT07105553
What this trial is testing

Glove Compression for Chemotherapy-Induced Neuropathy

Who this might be right for
Chemotherapy-induced Peripheral Neuropathy (CIPN)Gynecologic CancersOvarian Cancer (OvCa)+1 more
Ankara Etlik City Hospital 76
Testing effectiveness (Phase 2)Ended earlyNCT02107378
What this trial is testing

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Who this might be right for
Epithelial Ovarian Carcinoma
SOTIO a.s. 22
Testing effectiveness (Phase 2)Looking for participantsNCT06051695
What this trial is testing

Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNSCLC+17 more
A2 Biotherapeutics Inc. 474
Not applicableActive Not RecruitingNCT07009743
What this trial is testing

O-RADS MRI System on Early Detection of Ovarian Cancer

Who this might be right for
Ovarian Cancer (OvCa)Ovarian Cancer Metastatic
Shanghai Gynecologic Oncology Group 2,549
Early research (Phase 1)Ended earlyNCT02122146
What this trial is testing

PF-06664178 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 31
Testing effectiveness (Phase 2)Looking for participantsNCT07050771
What this trial is testing

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Who this might be right for
Hepatopancreaticobiliary (HPB) MalignancyOvarian Cancer (OvCa)Kidney Cancers+1 more
The Methodist Hospital Research Institute 148
Testing effectiveness (Phase 2)Study completedNCT00129727
What this trial is testing

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)

Who this might be right for
Ovarian Cancer
Massachusetts General Hospital 62
Testing effectiveness (Phase 2)Study completedNCT02107937
What this trial is testing

Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian NeoplasmsOvarian Epithelial Cancer
SOTIO a.s. 136
Early research (Phase 1)Study completedNCT02222922
What this trial is testing

PF-06647020 For Adult Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 138
Large-scale testing (Phase 3)WithdrawnNCT03905902
What this trial is testing

DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Carcinoma
SOTIO a.s.
Not applicableNot Yet RecruitingNCT07586449
What this trial is testing

A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer (OvCa)
Zhejiang Cancer Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT04834544
What this trial is testing

Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care

Who this might be right for
Epithelial Ovarian CarcinomaFallopian Tube CarcinomaPrimary Peritoneal Carcinoma
Peking University Third Hospital 75
Testing effectiveness (Phase 2)Study completedNCT02107950
What this trial is testing

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian NeoplasmsOvarian Cancer (OvCa)Ovarian Epithelial Cancer
SOTIO a.s. 71
Large-scale testing (Phase 3)Looking for participantsNCT07546500
What this trial is testing

Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression

Who this might be right for
Ovarian Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 420
Next Page